IDEAYA Biosciences Grants Equity Awards to New Employees
IDEAYA Biosciences has issued equity-based inducement grants to new staff members, continuing its practice of using stock awards for talent acquisition.
IDEAYA Biosciences, a South San Francisco-based firm specializing in precision oncology, disclosed on October 30, 2026, that it granted equity awards to newly hired employees. The grants were approved by the company's compensation committee on October 29, 2026.
The awards consist of options to purchase 33,600 shares of the company’s common stock and 13,800 restricted stock units. These grants were issued as a material inducement for employment under Nasdaq Listing Rule 5635(c)(4).
This move aligns with standard industry practice in the biotechnology sector, where equity compensation is frequently utilized to attract specialized researchers and corporate talent. The stock options carry an exercise price equal to the closing price of IDEAYA's common stock on the grant date, vesting over a four-year period.